Literature DB >> 35608699

Prevertebral cervical approach to posterior mediastinum parathyroid adenomas.

Mercedes Rubio-Manzanares Dorado1, Verónica Pino-Diaz2, Javier Padillo-Ruíz1, Juan Manuel Martos-Martínez1.   

Abstract

BACKGROUND: About 4 years ago, we described the pure endoscopic cervical approach to posterior mediastinum parathyroid adenomas, which we called the "prevertebral cervical approach". At that time, we had operated on three patients and did not have enough quality videos to demonstrate this approach. After broadening our experience, we present our results and show this technique through a video.
METHODS: From June 2015 to January 2021, information on patients undergoing the prevertebral cervical approach was obtained from a specific prospective database, including clinical presentation, biochemistry, preoperative imaging, surgical approach and patient outcomes. The step by step technique is described for both right- and left-sided adenomas, by means of a short video clip.
RESULTS: Ten patients were operated on using this technique. Seven adenomas were right-sided and three were left-sided. The mean surgical time was 33 ± 7 min. There were neither intraoperative nor major postoperative complications. Seven patients presented with a slight subcutaneous emphysema, which did not cause complaints. All patients were discharged the day after surgery, except for one patient with a previous open neck removal of four glands due to secondary hyperparathyroidism, which required calcium replacement. Calcium and parathyroid hormone levels were normalised in the other nine patients after surgery. One patient experienced a transient recurrent laryngeal nerve injury which was spontaneously resolved within 1 month. No permanent recurrent laryngeal nerve injury was found. The postoperative cosmetic outcomes were excellent.
CONCLUSION: In our experience, the pure cervical endoscopic approach has shown a high feasibility and short operation time, with excellent postoperative results regarding patient comfort, length of stay and disease cure. This approach also offers a very reasonable procedure cost, and may result in a less aggressive surgical option when compared with thoracic approaches.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Endoscopic parathyroidectomy; Mediastinum adenomas; Parathyroid gland ectopia; Prevertebral cervical approach

Mesh:

Substances:

Year:  2022        PMID: 35608699     DOI: 10.1007/s00464-022-09279-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  6 in total

1.  Transoral endoscopic parathyroidectomy vestibular approach: A systematic review.

Authors:  Payam Entezami; Lindsay Boven; Erin Ware; Brent A Chang
Journal:  Am J Otolaryngol       Date:  2020-10-25       Impact factor: 1.808

2.  Results of reoperation for hyperparathyroidism, with evaluation of preoperative localization studies.

Authors:  A J Edis; P F Sheedy; O H Beahrs; J A van Heerden
Journal:  Surgery       Date:  1978-09       Impact factor: 3.982

3.  Transoral endoscopic parathyroidectomy vestibular approach: a novel scarless parathyroid surgery.

Authors:  Thanyawat Sasanakietkul; Pornpeera Jitpratoom; Angkoon Anuwong
Journal:  Surg Endosc       Date:  2016-12-28       Impact factor: 4.584

Review 4.  Robotic thoracoscopic mediastinal parathyroidectomy for persistent hyperparathyroidism: case report and review of the literature.

Authors:  Adrian Harvey; Linda Bohacek; Donald Neumann; Tomislav Mihaljevic; Eren Berber
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-02       Impact factor: 1.719

5.  The mediastinal parathyroid.

Authors:  J M Conn; M A Goncalves; K A Mansour; W C McGarity
Journal:  Am Surg       Date:  1991-01       Impact factor: 0.688

6.  Thoracoscopic excision of enlarged mediastinal parathyroid glands.

Authors:  R A Prinz; V Lonchyna; B Carnaille; A Wurtz; C Proye
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.